Notably, a prior study applying the same ICR protocol to MMTV-neu mice -previously applied to MMTV-TGF-ɑ mice- reported tumor incidences 37% in AL-fed mice and 22% in ICR mice [76], suggesting that ICR might be effective in reducing the MT incidence regardless of the model. The gene discussed is ERBB2; the disease is cancer.